SLC16A1 and cholangiocarcinoma: For instance, Huang et al. found that downregulating the expression of SLC16A1 through RNA interference technology effectively inhibited the proliferation of cholangiocarcinoma cells and enhanced their sensitivity to the commonly used chemotherapeutic drug 5-fluorouracil 33.